CDH1 and breast cancer: KCL617, arising from a breast cancer of apocrine morphology, displayed a frameshift CDH1 mutation in both primary tumour and CSF cfDNA, with additional CDH1 loss of heterozygosity (LOH) in the CSF cfDNA.